Nav: Home

Targeting depression: Researchers ID symptom-specific targets for treatment of depression

May 04, 2020

BOSTON - Depression is the leading cause of disability worldwide, striking as many as one in four women and one in eight men in their lifetime. While more than 17 million adults in the United States struggled with the disease in 2017 according to the most recent government statistics, clinicians have long recognized that depression manifests in different ways across individuals; official diagnostic criteria include weight loss or weight gain, excessive sleeping or insomnia, inability to concentrate or obsessive rumination. However, the field of psychiatry has yet to reach a consensus classification of depression subtypes based on distinct clinical features, nor have prior proposed classification schemes improved treatment outcomes.

Now, for the first time, physician-scientists at Beth Israel Deaconess Medical Center (BIDMC) have identified two clusters of depressive symptoms that responded to two distinct neuroanatomical treatment targets in patients who underwent transcranial magnetic brain stimulation (TMS) for treatment of depression. The team's findings, which were published in the American Journal of Psychiatry, shed new light on the brain circuitry underlying specific symptoms of depression and may facilitate personalized TMS therapy for depression and other psychiatric or neurological disorders.

"We've known for over a century that different brain regions have different functions, and now we can finally translate this into symptom-specific treatment targets," said Shan H. Siddiqi, MD, a neuropsychiatrist in the Division of Cognitive Neurology at BIDMC and an Instructor in Psychiatry at Harvard Medical School. "We hope this discovery will help to usher in a new era of personalized medicine in psychiatry."

A non-invasive procedure that affects brain activity with powerful magnetic fields, TMS was approved for the treatment of depression in adults who did not benefit from antidepressant drugs in 2008. Currently, TMS practitioners use head measurements to position the machine's magnetic coil outside the patient's scalp - resulting in some incidental variation in the brain circuitry stimulated. Despite the imprecision, the well-tolerated therapy has about a 50 to 60 percent success rate, higher than most antidepressant drugs.

Taking advantage of that variation, Siddiqi and colleagues, including senior author Michael D. Fox, MD, PhD, Director of the Laboratory for Brain Network Imaging and Modulation at BIDMC and an Associate Professor of Neurology at Harvard Medical School, analyzed outcomes for two independent cohorts of patients who underwent TMS for treatment-resistant depression. Patients' symptoms were self-reported with a validated questionnaire as well as assessed by clinicians.

Siddiqi and colleagues mapped each patient's TMS site to underlying brain circuits - a technique pioneered by Fox at BIDMC - and compared these maps to the total change in depression symptoms across subjects. The analysis identified two distinct clusters of depressive symptoms, with each responding better to a different TMS target. One cluster included symptoms such as sadness, decreased interest, and suicidality, while a smaller cluster included symptoms such as irritability, sexual disinterest and insomnia. The researchers referred to these symptom clusters as "dysphoric" and "anxiosomatic," respectively.

Next, to validate the analysis' findings, the scientists used these cluster maps to accurately predict clinical improvement in a separate set of patients. The team's findings are consistent with recent studies identifying different symptom clusters - or biotypes - in people with depression. However, Siddiqi and Fox's study takes the reverse approach.

"Rather than identify biotypes and then searching for ways to treat them, we started with therapeutic response to an anatomically targeted treatment," said Siddiqi. "Our novel approach harnesses TMS to causally link neuro-anatomy and behavior. We started with depression and anxiety, but this approach could also be used to find a treatment target for any cluster of psychiatric symptoms."
-end-
In addition to Siddiqi and Fox, authors included Danielle Cook; Alvaro Pascual-Leone of Hebrew Senior Life and Harvard Medical School; Stephan F. Taylor of the University of Michigan School of Medicine; and Mark S. George of the Medical University of South Carolina.

This work was supported by the Sidney R. Baer Foundation.

Shan is a scientific consultant for SigNeuro lLC and Kaizen Brain Center.

About Beth Israel Deaconess Medical Center

Beth Israel Deaconess Medical Center is a patient care, teaching and research affiliate of Harvard Medical School and consistently ranks as a national leader among independent hospitals in National Institutes of Health funding. For more information, visit http://www.bidmc.org.

BIDMC is part of Beth Israel Lahey Health, a new health care system that brings together academic medical centers and teaching hospitals, community and specialty hospitals, more than 4,000 physicians

Beth Israel Deaconess Medical Center

Related Depression Articles:

Children with social anxiety, maternal history of depression more likely to develop depression
Although researchers have known for decades that depression runs in families, new research from Binghamton University, State University of New York, suggests that children suffering from social anxiety may be at particular risk for depression in the future.
Depression and use of marijuana among US adults
This study examined the association of depression with cannabis use among US adults and the trends for this association from 2005 to 2016.
Maternal depression increases odds of depression in offspring, study shows
Depression in mothers during and after pregnancy increased the odds of depression in offspring during adolescence and adulthood by 70%.
Targeting depression: Researchers ID symptom-specific targets for treatment of depression
For the first time, physician-scientists at Beth Israel Deaconess Medical Center have identified two clusters of depressive symptoms that responded to two distinct neuroanatomical treatment targets in patients who underwent transcranial magnetic brain stimulation (TMS) for treatment of depression.
A biological mechanism for depression
Researchers report that in depressed individuals there are increased amounts of an unmodified structural protein, called tubulin, in lipid rafts compared with non-depressed individuals.
Depression in adults who are overweight or obese
In an analysis of primary care records of 519,513 UK adults who were overweight or obese between 2000-2016 and followed up until 2019, the incidence of new cases of depression was 92 per 10,000 people per year.
Why stress doesn't always cause depression
Rats susceptible to anhedonia, a core symptom of depression, possess more serotonin neurons after being exposed to chronic stress, but the effect can be reversed through amygdala activation, according to new research in JNeurosci.
Which comes first: Smartphone dependency or depression?
New research suggests a person's reliance on his or her smartphone predicts greater loneliness and depressive symptoms, as opposed to the other way around.
Depression breakthrough
Major depressive disorder -- referred to colloquially as the 'black dog' -- has been identified as a genetic cause for 20 distinct diseases, providing vital information to help detect and manage high rates of physical illnesses in people diagnosed with depression.
CPAP provides relief from depression
Researchers have found that continuous positive airway pressure (CPAP) treatment of obstructive sleep apnea (OSA) can improve depression symptoms in patients suffering from cardiovascular diseases.
More Depression News and Depression Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Sound And Silence
Sound surrounds us, from cacophony even to silence. But depending on how we hear, the world can be a different auditory experience for each of us. This hour, TED speakers explore the science of sound. Guests on the show include NPR All Things Considered host Mary Louise Kelly, neuroscientist Jim Hudspeth, writer Rebecca Knill, and sound designer Dallas Taylor.
Now Playing: Science for the People

#576 Science Communication in Creative Places
When you think of science communication, you might think of TED talks or museum talks or video talks, or... people giving lectures. It's a lot of people talking. But there's more to sci comm than that. This week host Bethany Brookshire talks to three people who have looked at science communication in places you might not expect it. We'll speak with Mauna Dasari, a graduate student at Notre Dame, about making mammals into a March Madness match. We'll talk with Sarah Garner, director of the Pathologists Assistant Program at Tulane University School of Medicine, who takes pathology instruction out of...
Now Playing: Radiolab

Kittens Kick The Giggly Blue Robot All Summer
With the recent passing of Ruth Bader Ginsburg, there's been a lot of debate about how much power the Supreme Court should really have. We think of the Supreme Court justices as all-powerful beings, issuing momentous rulings from on high. But they haven't always been so, you know, supreme. On this episode, we go all the way back to the case that, in a lot of ways, started it all.  Support Radiolab by becoming a member today at Radiolab.org/donate.